INFINEON BAL99

BAL99...
Silicon Switching Diode
• For high-speed switching applications
• Pb-free (RoHS compliant) package 1)
• Qualified according AEC Q101
BAL99
!
Type
BAL99
Package
SOT23
Configuration
single
Marking
JFs
Maximum Ratings at TA = 25°C, unless otherwise specified
Parameter
Symbol
Value
Unit
Diode reverse voltage
VR
80
Peak reverse voltage-
VRM
85
Forward current
IF
250
Peak forward current
IFM
-
Surge forward current, t = 1 µs
IFS
4.5
A
Total power dissipation
Ptot
370
mW
Junction temperature
Tj
150
°C
Storage temperature
Tstg
Thermal Resistance
Parameter
Symbol
Value
Unit
Junction - soldering point 2)
RthJS
≤ 260
K/W
V
mA
TS ≤ 54°C
-65 ... 150
1Pb-containing
2For
package may be available upon special request
calculation of RthJA please refer to Application Note Thermal Resistance
1
2007-04-19
BAL99...
Electrical Characteristics at TA = 25°C, unless otherwise specified
Symbol
Values
Unit
Parameter
min.
typ. max.
DC Characteristics
85
V
Breakdown voltage
V(BR)
I(BR) = 100 µA
Reverse current
IR
µA
VR = 70 V
-
-
1
VR = 25 V, TA = 150 °C
-
-
30
VR = 70 V, TA = 150 °C
-
-
50
Forward voltage
mV
VF
IF = 1 mA
-
-
715
IF = 10 mA
-
-
855
IF = 50 mA
-
-
1000
IF = 150 mA
-
-
1250
CT
-
-
1.5
pF
trr
-
-
4
ns
AC Characteristics
Diode capacitance
VR = 0 V, f = 1 MHz
Reverse recovery time
IF = 10 mA, IR = 10 mA, measured at IR = 1mA ,
RL = 100 Ω
Test circuit for reverse recovery time
D.U.T.
ΙF
Puls generator: tp = 100ns, D = 0.05,
tr = 0.6ns, Ri = 50Ω
Oscillograph
EHN00014
Oscillograph: R = 50, tr = 0.35ns
C ≤ 1pf
2
2007-04-19
BAL99...
Reverse current IR = ƒ (TA)
Forward Voltage VF = ƒ (TA)
IF = Parameter
VR = Parameter
10 5
BAL 99
EHB00007
BAL 99
1.0
nA
V
ΙR
Ι F = 100 mA
VF
VR = 70 V
10 4
EHB00010
max.
5
10 mA
70V
10 3
25V
1 mA
0.5
5
0.1 mA
typ.
10 2
5
10 1
0
50
100
˚C
0
150
0
50
100
˚C
TA
150
TA
Forward current IF = ƒ (VF)
Peak forward current IFM = ƒ (tp)
TA = 25°C
150
ΙF
BAL 99
EHB00008
10 2
Ι FM
mA
BAL 99
EHB00009
D = 0.005
0.01
0.02
0.05
0.1
0.2
A
10 1
100
typ
10 0
max
50
10 -1
tp
D=
tp
T
T
0
0
0.5
1.0
V
10-2
10-6
1.5
VF
10-5
10-4
10-3
10-2
10-1 s 100
t
3
2007-04-19
BAL99...
Forward current IF = ƒ (T S)
300
mA
IF
200
150
100
50
0
0
15
30
45
60
75
90 105 120 °C
150
TS
4
2007-04-19
Package SOT23
BAL99...
0.4 +0.1
-0.05
1)
2
0.08...0.1
C
0.95
1.3 ±0.1
1
2.4 ±0.15
3
0.1 MAX.
10˚ MAX.
B
1 ±0.1
10˚ MAX.
2.9 ±0.1
0.15 MIN.
Package Outline
A
5
0...8˚
1.9
0.2
0.25 M B C
M
A
1) Lead width can be 0.6 max. in dambar area
Foot Print
0.8
0.9
1.3
0.9
0.8
1.2
Marking Layout (Example)
Manufacturer
EH s
2005, June
Date code (YM)
Pin 1
BCW66
Type code
Standard Packing
Reel ø180 mm = 3.000 Pieces/Reel
Reel ø330 mm = 10.000 Pieces/Reel
4
0.2
8
2.13
2.65
0.9
Pin 1
1.15
3.15
5
2007-04-19
BAL99...
Edition 2006-02-01
Published by
Infineon Technologies AG
81726 München, Germany
© Infineon Technologies AG 2007.
All Rights Reserved.
Attention please!
The information given in this dokument shall in no event be regarded as a guarantee
of conditions or characteristics (“Beschaffenheitsgarantie”). With respect to any
examples or hints given herein, any typical values stated herein and/or any information
regarding the application of the device, Infineon Technologies hereby disclaims any
and all warranties and liabilities of any kind, including without limitation warranties of
non-infringement of intellectual property rights of any third party.
Information
For further information on technology, delivery terms and conditions and prices
please contact your nearest Infineon Technologies Office ( www.infineon.com).
Warnings
Due to technical requirements components may contain dangerous substances.
For information on the types in question please contact your nearest
Infineon Technologies Office.
Infineon Technologies Components may only be used in life-support devices or
systems with the express written approval of Infineon Technologies, if a failure of
such components can reasonably be expected to cause the failure of that
life-support device or system, or to affect the safety or effectiveness of that
device or system.
Life support devices or systems are intended to be implanted in the human body,
or to support and/or maintain and sustain and/or protect human life. If they fail,
it is reasonable to assume that the health of the user or other persons
may be endangered.
6
2007-04-19